Vertex Selects Drug Combo, a Potential Therapy for 90% of CF Patients - Xconomy

Vertex Selects Drug Combo, a Potential Therapy for 90% of CF Patients  Xconomy

Vertex Pharmaceuticals is already a leader in cystic fibrosis therapies. The company is placing its bet on an experimental drug that could strengthen its.